Philadelphia’s first Roundup trial kicked off Tuesday in front of a packed courtroom, with plaintiffs counsel advancing a new claim that has started to emerge in recent litigation over the weedkiller.

Thomas Kline of Kline & Specter, making his opening statement for the plaintiff, asserted that Roundup’s alleged cancer-causing properties are rooted in more than just its active ingredient, glyphosate. He called another ingredient, surfactant, “a problem chemical,” and said it was one of multiple harmful substances in Roundup that were not listed on the product’s packaging.

This content has been archived. It is available through our partners, LexisNexis® and Bloomberg Law.

To view this content, please continue to their sites.

Not a Lexis Subscriber?
Subscribe Now

Not a Bloomberg Law Subscriber?
Subscribe Now

Why am I seeing this?

LexisNexis® and Bloomberg Law are third party online distributors of the broad collection of current and archived versions of ALM's legal news publications. LexisNexis® and Bloomberg Law customers are able to access and use ALM's content, including content from the National Law Journal, The American Lawyer, Legaltech News, The New York Law Journal, and Corporate Counsel, as well as other sources of legal information.

For questions call 1-877-256-2472 or contact us at [email protected]